Carter-Wallace Felbatol (correction)
Executive Summary
Carter-Wallace's Felbatol (felbamate) is restricted to second-line use in adults with epilepsy and as adjunctive therapy in the treatment of partial and generalized seizures associated with Lennox-Gastaut syndrome in children due to risk of aplastic anemia and liver failure. "The Pink Sheet" (Aug. 27, p. 29) incorrectly reported that Felbatol had been withdrawn